UBE3A deletion enhances the efficiency of immunotherapy in non-small-cell lung cancer

Immunotherapy significantly improves the prognosis of advanced lung cancer. It has become an important treatment option for advanced lung cancer. However, there remain many limitations in clinical treatment, and only a small portion of patients can benefit from immunotherapy. Our study aimed to iden...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Nan, Shen, Jie, Gou, Lanying, Cao, Manming, Ding, Weimin, Luo, Peng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275990/
https://www.ncbi.nlm.nih.gov/pubmed/35531878
http://dx.doi.org/10.1080/21655979.2022.2069328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275990/
https://www.ncbi.nlm.nih.gov/pubmed/35531878
http://dx.doi.org/10.1080/21655979.2022.2069328

Ejemplares similares